A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

BACKGROUND: To reveal roles of reactive oxygen species (ROS) status in chemotherapy resistance and to develop a ROS scoring system for prognosis prediction in ovarian cancer. METHODS: We tested the sensitizing effects of ROS elevating drugs to cisplatin (cDDP) in ovarian cancer both in vitro and in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Sun, Chaoyang, Guo, Ensong, Zhou, Bo, Shan, Wanying, Huang, Jia, Weng, Danhui, Wu, Peng, Wang, Changyu, Wang, Shixuan, Zhang, Wei, Gao, Qinglei, Xu, Xiaoyan, Wang, Beibei, Hu, Junbo, Ma, Ding, Chen, Gang
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6839150/
https://ncbi.nlm.nih.gov/pubmed/31703584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6288-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi